Gastrointestinal tolerability of diclofenac epolamine topical patch 1.3%: A pooled analysis of 14 clinical studies

Postgraduate Medicine

Volumn 123, Issue 4, 2011, Pages 168-176

  Brewer, Alan R ^a   Pierchala, Lisa A ^b   Yanchick, Jillmarie K ^c   Magelli, Merrell ^c,d   Rovati, Stefano ^e  

^a Spinal Diagnostic/Pain Care Specialists   (United States)

^b MMS HOLDINGS INC   (United States)

^c PFIZER INC   (United States)

^d GTx Inc   (United States)

^e Institut Biochimique SA   (Switzerland)

Author keywords

Acute pain; Adverse event; Nonsteroidal anti inflammatory drug; Topical patch

Indexed keywords

DICLOFENAC; DICLOFENAC EPOLAMINE; PLACEBO;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGED; ANEMIA; ARTICLE; DIARRHEA; DIGESTIVE SYSTEM ULCER; DRUG DOSAGE FORM COMPARISON; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GENDER; GROUPS BY AGE; HUMAN; MALE; NAUSEA; OUTCOMES RESEARCH; PAIN; SHORT COURSE THERAPY; SKIN TOXICITY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VOMITING;

ADULT; AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; FEMALE; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; PAIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS; TRANSDERMAL PATCH;

EID: 79960311445     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2011.07.2316     Document Type: Article

References (49)

1. Elnachef N, Scheiman JM, Fendrick AM, Howden CW, Chey WD. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers. Aliment Pharmacol Ther. 2008;28(10):1249-1258.
2. Laine L. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors. Semin Arthritis Rheum. 2002;32(3 suppl 1):25-32.
3. Fujimori S, Gudis K, Takahashi Y, et al. Distribution of small intestinal mucosal injuries as a result of NSAID administration. Eur J Clin Invest. 2010;40(6):504-510.
4. Goldstein JL, Aisenberg J, Lanza F, et al. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. Clin Ther. 2006;28(3):340-351.
5. Miglioli M, Bianchi PG, Vaira D, et al. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients. Am J Gastroenterol. 1996;91(11):2367-2371.
6. Goldstein JL, Jungwirthová A, David J, et al. Clinical trial: endoscopic evaluation of naproxen etemesil, a naproxen prodrug, vs. naproxen-a proof-of-concept, randomized, double-blind, active-comparator study. Aliment Pharmacol Ther. 2010;32(9):1091-1101.
7. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology. 2001;120(3):594-606.
8. Lanas A, Serrano P, Bajador E, Esteva F, Benito R, Sáinz R. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology. 1997;112(3):683-689.
9. Gyires K. Gastric mucosal protection: from prostaglandins to genetherapy. Curr Med Chem. 2005;12(2):203-215.
10. Singh G, Fort JG, Goldstein JL, et al; SUCCESS-I Investigators. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Am J Med. 2006;119(3):255-266.
11. Zarraga IG, Schwarz ER. Coxibs and heart disease: what we have learned and what else we need to know. J Am Coll Cardiol. 2007;49(1):1-14.
12. Stanos SP. Topical agents for the management of musculoskeletal pain. J Pain Symptom Manage. 2007;33(3):342-355.
13. Evans JM, McMahon AD, McGilchrist MM, et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ. 1995;311(6996):22-26.
14. Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases. Drugs. 2000;60(3):555-574.
15. Fini A, Fazio G, Rapaport I. Dicolfenac/N-(2-hydroxyethyl)pyrrolidine: a new salt for an old drug. Drugs Exp Clin Res. 1993;19(3):81-88.
16. Petersen B, Rovati S. Diclofenac epolamine (Flector) patch: evidence for topical activity. Clin Drug Investig. 2009;29(1):1-9.
17. Assandri A, Canali S, Giachetti C. Local tolerability and pharmacokinetic profile of a new transdermal delivery system, diclofenac hydroxyethylpyrrolidine plaster. Drugs Exp Clin Res. 1993;19(3):89-95.
18. Gallacchi G, Marcolongo R. Pharmacokinetics of diclofenac hydroxyethylpyrrolidine (DHEP) plasters in patients with monolateral knee joint effusion. Drugs Exp Clin Res. 1993;19(3):95-97.
19. Galer BS, Rowbotham M, Perander J, Devers A, Friedman E. Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial. J Pain Symptom Manage. 2000;19(4):287-294.
20. Rowbotham MC, Galer BS, Block JA, Backonja MM. Flector Tissugel®: efficacy and safety in the treatment of minor sports injuries. Data from a controlled trial in the United States [in French]. J Traumatol Sport. 2003;20:1S15-1S20.
21. Saillant G. Study comparing the efficacy and tolerance of Flector Tissugel® to that of a placebo in the treatment of benign ankle sprains [in French]. Médecine du Sport. 1998;72:1-5.
22. Joussellin É. Flector Tissugel® in the treatment of painful ankle sprain [in French]. J Traumatol Sport. 2003;20:1S5-1S9.
23. Funk L, Umaar R, Molajo A. Diclofenac patches for postoperative shoulder pain. Int J Shoulder Surg. 2008;2(2):47-48.
24. Jenoure PJ, Rostan A, Gremion G, et al. Multicenter, double-blind, controlled clinical study on the efficacy of diclofenac epolamine-Tissugel plaster in patients with epicondylitis. Medicina dello Sport. 1997;50(3):285-292.
25. Brühlmann P, Michel BA. Topical diclofenac patch in patients with knee osteoarthritis: a randomized, double-blind, controlled clinical trial. Clin Exp Rheumatol. 2003;21(2):193-198.
26. Dreiser RL, Tisne-Camus M. DHEP plasters as a topical treatment of knee osteoarthritis-a double-blind placebo-controlled study. Drugs Exp Clin Res. 1993;19(3):117-123.
27. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract. 2004;5:10.
28. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for chronic musculoskeletal pain: systematic review and metaanalysis. BMC Musculoskeletal Disorders. 2004;5:28.
29. Moore RA, Tramér MR, Carroll D, Wiffen PJ, McQuay HJ. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ. 1998;316(7128):333-338.
30. Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomized controlled trials. BMJ. 2004;329(7461):324.
31. Rusca A, Mautone G, Sun S, Magelli M, Johnson F. Comparison of plasma pharmacokinetics of FLECTOR® Patch (diclofenac epolamine topical patch) and oral Voltaren® (diclofenac sodium enteric-coated tablets) in healthy volunteers. Poster presented at: 27th Annual Scientific Meeting of the American Pain Society; May 8-10, 2008; Tampa, FL.
32. Kuehl K, Carr W, Yanchick JK, Magelli, Rovati S. Analgesic efficacy and safety of the diclofenac epolamine topical patch in minor soft tissue injury [published online ahead of print May 11, 2011]. Int J Sports Med.
33. Camarri E. Clinical efficacy and tolerability of diclofenac epolamine: a new drug delivery system in patients with inflammatory diseases. Grosseto (Italy): Rheumatology Department, Grosseto Hospital Unit; 1991. Sponsored by Institut Biochimique SA, Pambio-Noranco, Switzerland.
34. Galeazzi M, Marcolongo R. A placebo-controlled study of the efficacy and tolerability of a nonsteroidal anti-inflammatory drug, DHEP plaster, in inflammatory peri-and extra-articular rheumatological diseases. Drugs Exp Clin Res. 1993;19(3):107-115.
35. Arroyo JF, Benguettat D, Hermann F, Zelger G, Michel JP. A study of the short-term efficacy of Flector EP-Tissugel (diclofenac epolamine) for the local treatment of abarticular pathologies of the shoulder and the knee in elderly subjects. In: Mautone G, ed. Proceedings from the 1st Symposium IBSA on the Therapeutic Progress in the Local Treatment of Rheumatic and Traumatic Diseases; June 4, 1994. Lugano, Switzerland; 83-92.
36. Rosenthal M, Bahous I. A controlled clinical study on the new topical dosage form of DHEP plasters in patients suffering from localized inflammatory diseases. Drugs Exp Clin Res. 1993;19(3):99-105.
37. Jenoure P, Segesser B, Lühti U, Gremion G. A trial with diclofenac HEP plaster as topical treatment in minor sport injuries. Drugs Exp Clin Res. 1993;19(3):125-131.
38. Angehrn F. Ein neuer Ansatz in der Behandlung von Patienten mit akuter Thrombophlebitis. Hautnah Schweiz. 1999;5:3-11.
39. Laine L. Gastrointestinal effects of NSAIDs and coxibs. J Pain Symptom Manage. 2003;25(2 suppl):S32-S40.
40. Ekman EF, Fiechtner JJ, Levy S, Fort JG. Efficacy of celecoxib versus ibuprofen in the treatment of acute pain: a multicenter, double-blind, randomized controlled trial in acute ankle sprain. Am J Orthop. 2002;31(8):445-451.
41. Petrella R, Ekman E, Schuller R, Fort JG. Efficacy of celecoxib, a COX-2-specific inhibitor, and naproxen in the management of acute ankle sprain: results of a double-blind, randomized controlled trial. Clin J Sport Med. 2004;14(4):225-231.
42. Bertin P, Béhier JM, Noël E, Leroux JL. Celecoxib is as efficacious as naproxen in the management of acute shoulder pain. J Int Med Res. 2003;31(2):102-112.
43. Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroentrol. 1998;93(11):2037-2046.
44. Voskuyl AE, Van de Laar MA, Moens HJ, Van der Korst JK. Extraarticular manifestations of rheumatoid arthritis: risk factors for serious gastrointestinal events. Ann Rheum Dis. 1993;52(11):771-775.
45. Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med. 2002;162(19):2197-2202.
46. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled clinical trials. JAMA. 2006;295(3):306-313.
47. Pilotto A, Franceschi M, Leandro G, Di Mario F; Geriatric Gastroenterology Study Group (Societè Italiana Gerontologie Geriatria). NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies. Drugs Aging. 2003;20(9):701-710.
48. Buffum M, Buffum JC. Nonsteroidal anti-inflammatory drugs in the elderly. Pain Manag Nurs. 2000;1(2):40-50.
49. Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol. 2004;31(10):2002-2012.